Home > Insider Trading > Filing (0000899243-22-026684)

Filing Details

Accession Number:: 0000899243-22-026684
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-07-25 19:35:38
Reporting Period:: 2022-07-19

Accepted Time:: 2022-07-25 19:35:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1827506	Talaris Therapeutics Inc.	TALS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365343	Francois Nader	C/O Talaris Therapeutics, Inc. 93 Worcester Street Wellesley MA 02481		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-07-19	50,000	$3.52	50,000	No	4	P	Direct
Common Stock	Acquisiton	2022-07-20	52,000	$3.62	102,000	No	4	P	Direct
Common Stock	Disposition	2022-07-21	248,432	$0.00	87,735	No	5	J	Indirect	By Francois Nader 2020 Trust
Common Stock	Acquisiton	2022-07-21	248,432	$0.00	248,432	No	5	J	Indirect	By FN TALS LLC
Common Stock	Acquisiton	2022-07-21	36,500	$3.72	138,500	No	4	P	Direct
Common Stock	Disposition	2022-07-25	138,500	$0.00	0	No	5	J	Direct
Common Stock	Acquisiton	2022-07-25	138,500	$0.00	386,932	No	5	J	Indirect	By FN TALS LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	5	J	Indirect	By Francois Nader 2020 Trust
No	5	J	Indirect	By FN TALS LLC
No	4	P	Direct
No	5	J	Direct
No	5	J	Indirect	By FN TALS LLC

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.38 to $3.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.51 to $3.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents the transfer of shares held by the Francois Nader 2020 Trust to FN TALS LLC for no consideration.
These shares are held in a trust for the benefit of the Reporting Person's spouse and child. The Reporting Person's spouse and child are trustees of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
These shares are held by a limited liability company of which the Reporting Person serves as the sole member, with sole voting and investment control over the securities held thereby. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.595 to $3.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Represents the transfer of shares held by the Reporting Person to FN TALS LLC for no consideration.